These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18379536)

  • 1. Amino-acid-based peritoneal dialysis solution improves amino-acid transport into skeletal muscle.
    Asola M; Virtanen K; Någren K; Helin S; Taittonen M; Kastarinen H; Anderstam B; Knuuti J; Metsärinne K; Nuutila P
    Kidney Int Suppl; 2008 Apr; (108):S131-6. PubMed ID: 18379536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid uptake in the skeletal muscle measured using [11C]methylaminoisobutyrate (MEAIB) and PET.
    Asola MR; Virtanen KA; Peltoniemi P; Någren K; Yu M; Mattila K; Jyrkkiö S; Metsärinne K; Nuutila P; Knuuti J
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1485-91. PubMed ID: 12397468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of new peritoneal dialysis solutions in children.
    Canepa A; Verrina E; Perfumo F
    Kidney Int Suppl; 2008 Apr; (108):S137-44. PubMed ID: 18379537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis.
    Tjiong HL; van den Berg JW; Wattimena JL; Rietveld T; van Dijk LJ; van der Wiel AM; van Egmond AM; Fieren MW; Swart R
    J Am Soc Nephrol; 2005 May; 16(5):1486-93. PubMed ID: 15800130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure.
    Garibotto G; Sofia A; Canepa A; Saffioti S; Sacco P; Sala MR; Dertenois L; Pastorino N; Deferrari G; Russo R
    J Am Soc Nephrol; 2001 Mar; 12(3):557-567. PubMed ID: 11181804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino Acid-based peritoneal dialysis solutions for malnutrition: new perspectives.
    Tjiong HL; Swart R; van den Berg JW; Fieren MW
    Perit Dial Int; 2009; 29(4):384-93. PubMed ID: 19602603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution.
    Jones MR; Gehr TW; Burkart JM; Hamburger RJ; Kraus AP; Piraino BM; Hagen T; Ogrinc FG; Wolfson M
    Perit Dial Int; 1998; 18(2):210-6. PubMed ID: 9576371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of an amino acid-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass.
    Brulez HF; van Guldener C; Donker AJ; ter Wee PM
    Nephrol Dial Transplant; 1999 Jan; 14(1):154-9. PubMed ID: 10052496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?
    Martikainen TA; Teppo AM; Grönhagen-Riska C; Ekstrand AV
    Perit Dial Int; 2005; 25(5):453-60. PubMed ID: 16178478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal protein losses and cytokine generation in automated peritoneal dialysis with combined amino acids and glucose solutions.
    Tjiong HL; Zijlstra FJ; Rietveld T; Wattimena JL; Huijmans JG; Swart GR; Fieren MW
    Mediators Inflamm; 2007; 2007():97272. PubMed ID: 18274646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution.
    Van Biesen W; Boer W; De Greve B; Dequidt C; Vijt D; Faict D; Lameire N
    Perit Dial Int; 2004; 24(3):222-30. PubMed ID: 15185770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.
    Brulez HF; Dekker HA; Oe PL; Verbeelen D; ter Wee PM; Verbrugh HA
    Nephron; 1996; 74(1):26-32. PubMed ID: 8883016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1% amino acid peritoneal dialysate: single-cycle study in diabetic patients with end-stage renal disease.
    Arfeen S; Goodship TH; Kirkwood A; Channon S; Ward MK
    Am J Kidney Dis; 1994 Jan; 23(1):86-90. PubMed ID: 8285202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin and whole-body protein synthesis respond differently to intraperitoneal and oral amino acids.
    Tjiong HL; Fieren MW; Rietveld T; Wattimena JL; Schierbeek H; Huijmans JG; Hop WC; Swart GR; van den Berg JW
    Kidney Int; 2007 Aug; 72(3):364-9. PubMed ID: 17554255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding.
    Tjiong HL; Rietveld T; Wattimena JL; van den Berg JW; Kahriman D; van der Steen J; Hop WC; Swart R; Fieren MW
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):74-80. PubMed ID: 17699390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of kinetic characteristics of amino acid-based and dipeptide-based peritoneal dialysis solutions.
    Weryński A; Waniewski J; Wang T; Anderstam B; Lindholm B; Bergström J
    Int J Artif Organs; 2006 Jul; 29(7):681-90. PubMed ID: 16874673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of amino-acid-based versus glucose-based continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Schenk U; Kiefer T; Hübel E; Weber J; Mettang T; Passlick-Deetjen J; Kuhlmann U
    Nephron; 1994; 68(3):338-46. PubMed ID: 7838257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Carbamylation in Peritoneal Dialysis and the Effect of Low Glucose Plus Amino Acid Solutions.
    Trottier C; Perl J; Freeman M; Thadhani R; Berg A; Kalim S
    Perit Dial Int; 2018; 38(2):149-152. PubMed ID: 29563277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.